The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments

Clinical Pharmacokinetics
Nina G SchneiderE Lunell

Abstract

Nicotine inhaled in smoke is the most rapid form of delivery of the drug. With smoking, arterial boli and high venous blood nicotine concentrations are produced within seconds and minutes, respectively. The potency of nicotine as the primary reinforcement in tobacco addiction is attributed to this rapid rate of delivery. By design, nicotine treatments reduce the rate and extent of drug delivery for weaning from nicotine during smoking cessation. Theoretically, they prevent relapse by reducing withdrawal and craving associated with the abrupt cessation of cigarettes. The nicotine inhaler treats the complexity of smoking through weaning both from the drug and from the sensory/ritual components associated with smoking. The inhaler is 'puffed' but not lit and there is considerable 'puffing' required to achieve slower rising and lower nicotine concentrations. These factors allow it to be used as a nicotine reduction treatment. One inhaler contains 10 mg of nicotine (and 1 mg of menthol) of which 4 mg of nicotine can be extracted and 2mg are systemically available. Shallow or deep 'puffing' results in similar nicotine absorption. Nicotine is delivered mainly to the oral cavity, throat and upper respiratory tract with a minor fraction...Continue Reading

References

Jan 1, 1978·Drug Metabolism Reviews·M A Russell, C Feyerabend
Apr 23, 1977·British Medical Journal·M A RussellY Saloojee
Oct 30, 1976·British Medical Journal·S Sullivan, R Williams
May 1, 1976·British Medical Journal·M A RussellP V Cole
Sep 1, 1992·Clinical Pharmacokinetics·N G Schneider
Dec 1, 1991·British Journal of Addiction·M Farré, J Camí
Jan 1, 1991·European Journal of Clinical Pharmacology·C J JohanssonP O Gunnarsson
Apr 18, 1990·JAMA : the Journal of the American Medical Association·J E HenningfieldN L Benowitz
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J R Hughes
Sep 16, 1988·JAMA : the Journal of the American Medical Association·S R CummingsT J Coates
Jan 1, 1986·Annual Review of Medicine·N L Benowitz
Nov 1, 1986·American Journal of Public Health·D W SepkovicN J Haley
Apr 1, 1987·Clinical Pharmacology and Therapeutics·N L BenowitzC Savanapridi
Sep 1, 1985·Regulatory Toxicology and Pharmacology : RTP·G B Gori, C J Lynch
Jul 19, 1973·Psychopharmacologia·O Fernö
May 1, 1984·Drug and Alcohol Dependence·J E RoseK D Rose
Sep 26, 1981·British Medical Journal·M A RussellC Feyerabend
Jun 28, 1980·British Medical Journal·M A RussellM J Jarvis
Aug 20, 1982·JAMA : the Journal of the American Medical Association·M E McNabbK McCusker
Jan 1, 1980·Journal of Psychosomatic Research·M A Russell
Mar 1, 1995·Clinical Pharmacology and Therapeutics·M BergströmB Långström
Jan 1, 1995·Psychopharmacology·I P Stolerman, M J Jarvis
Jan 1, 1993·Psychopharmacology·D HatsukamiK Skoog
Jan 1, 1994·BMJ : British Medical Journal·J L TangN Wald
Jun 22, 1994·JAMA : the Journal of the American Medical Association·M C FioreT B Baker
Mar 10, 1993·JAMA : the Journal of the American Medical Association·P TønnesenF Nilsson
Apr 1, 1996·Clinical Pharmacology and Therapeutics·L MolanderF Kuylenstierna
Feb 1, 1996·Pharmacology, Biochemistry, and Behavior·E C WestmanJ E Rose
Aug 1, 1996·The European Respiratory Journal·P TønnesenS Jørgensen
Apr 1, 1997·Psychopharmacology·K J SchuhM L Stitzer
Mar 1, 1997·Addiction·N G SchneiderR E Olmstead

❮ Previous
Next ❯

Citations

Aug 28, 2013·Psychopharmacology·Lynne Dawkins, Olivia Corcoran
Sep 1, 2005·Psychopharmacology·Nina G SchneiderChris Cortner
Aug 10, 2006·Psychopharmacology·Shannon G MattaJeffrey M Zirger
Aug 10, 2006·Psychopharmacology·Nina G SchneiderDavid Leaf
Sep 10, 2011·Psychopharmacology·Daniel S McGrathEvan A Schmid
Jul 31, 2013·Biochemical Pharmacology·Gaurav Jain, Edgar A Jaimes
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Erik Lunell, Marianne Lunell
Apr 7, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Brent CaldwellJulian Crane
Mar 2, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Brent CaldwellJulian Crane
Apr 25, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jean-François Etter, Nina G Schneider
Dec 15, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Xuesi M ShaoJack L Feldman
Feb 24, 2006·Cardiology in Review·William H FrishmanTom Ky
Aug 21, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Marsha A IveyRichard Wood-Baker
Sep 19, 2008·Drug Development and Industrial Pharmacy·Kathleen SimisJim Cassella
Mar 25, 2014·Expert Opinion on Emerging Drugs·Muhamad Y Elrashidi, Jon O Ebbert
Nov 22, 2005·Expert Opinion on Drug Delivery·Saul ShiffmanJack E Henningfield
Mar 31, 2007·Preventive Cardiology·William H Frishman
Feb 28, 2006·Journal of the American Academy of Nurse Practitioners·Jenny Sigel Burkett
Jun 14, 2014·British Journal of Health Psychology·Russell R C HutterRosemary R C McEachan
Nov 5, 2011·Critical Reviews in Toxicology·Alessio CardinalePatrizia Russo
Dec 3, 2013·Addictive Behaviors·Karl Olov Fagerström, Kevin Bridgman
Oct 30, 2010·The International Journal of Neuropsychopharmacology·Irina EsterlisKelly P Cosgrove
Jan 27, 2015·Frontiers in Aging Neuroscience·George E BarretoValentina Echeverria Moran
Nov 12, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Chris MoysesAndrew Redfern
Aug 2, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Chris MoysesAndrew Redfern
Jun 10, 2016·Critical Reviews in Toxicology·Hans-Juergen Haussmann, Marc W Fariss
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Jose L BarbozaKaren Suchanek Hudmon
Jan 21, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kahina MedjberJean-Marie Tournier
Jun 6, 2009·Therapeutic Advances in Cardiovascular Disease·William H Frishman
May 10, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Axel TeichertFrank Lüdicke
Sep 14, 2016·The Cochrane Database of Systematic Reviews·Jamie Hartmann-BoycePeter Hajek
Sep 17, 2014·Journal of Neuroscience Research·Ozra DehkordiAnnapurni Jayam-Trouth
Aug 9, 2017·Addiction·Jean-François Etter
Apr 29, 2008·Human Psychopharmacology·Nina G SchneiderRichard E Olmstead
Apr 29, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Norbert H KleinsasserElmar Richter
Nov 11, 2008·Annals of the New York Academy of Sciences·Jed E Rose
Aug 27, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Andrea W SassenNorbert H Kleinsasser
Feb 20, 2009·Wiener medizinische Wochenschrift·Karl-Heinz MulzerErnest Groman
Mar 20, 2010·Internal Medicine Journal·T E Jones, J Williams
Mar 1, 2005·Pharmacological Reviews·Janne HukkanenNeal L Benowitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health Behavior
Nina G SchneiderShilpan Patel
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
Jae H ChoiKenneth R Strahs
© 2021 Meta ULC. All rights reserved